Amanote Research

Amanote Research

    RegisterSign In

Compassionate Use Programs or Phase IV Trials of Innovative Molecular Targeted Drugs in Lung Cancer: Deal or No Deal?

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e3181f41b1c
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineOncologyRespiratory MedicinePulmonary
Date

October 1, 2010

Authors
Wilfried Eberhardt
Publisher

Elsevier BV


Related search

Deal or No Deal?

Nursing standard (Royal College of Nursing (Great Britain) : 1987)
Medicine
2008English

Brexit: Deal or No Deal?

The Lancet
Medicine
2019English

Spending Review 2019: Deal or No Deal

2019English

Deal or No Deal: English Devolution, a Top-Down Approach

Lex Localis
LawPublic Administration
2016English

Real Deal or No Deal? A Comparative Analysis of Raw Milk Cheese Regulation in Australia and France

International Journal of Rural Law and Policy
2017English

Nix Nought Nothing: Fairy Tale or Real Deal

Journal of Molecular and Cellular Cardiology
Cardiovascular MedicineMolecular BiologyCardiology
2011English

US Blocks Deal on Cheap Drugs

BMJ
2003English

Tolerance or Toleration? How to Deal With Religious Conflicts in Europe

2011English

Innovative Technologies: Sweet Deal for Cocoa Production?

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy